HUP0303055A2 - Zaleplon polimorf módosulatai és eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények - Google Patents

Zaleplon polimorf módosulatai és eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0303055A2
HUP0303055A2 HU0303055A HUP0303055A HUP0303055A2 HU P0303055 A2 HUP0303055 A2 HU P0303055A2 HU 0303055 A HU0303055 A HU 0303055A HU P0303055 A HUP0303055 A HU P0303055A HU P0303055 A2 HUP0303055 A2 HU P0303055A2
Authority
HU
Hungary
Prior art keywords
zaleplon
polymorphs
preparation
methods
pharmaceutical compositions
Prior art date
Application number
HU0303055A
Other languages
English (en)
Inventor
Farhan Aslam
Stephen R. Byrn
Brett Cowans
G. Patrick Stahly
Original Assignee
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth filed Critical Wyeth
Publication of HUP0303055A2 publication Critical patent/HUP0303055A2/hu
Publication of HUP0303055A3 publication Critical patent/HUP0303055A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány zaleplon (N-[3-(3-cianopirazolo[1,5a]-pirimidin-7-il)fenil]-N-etilacetamid) új, kristályos polimorf módosulataira, ezekelőállítási eljárására, valamint ezen polimorf módosulatokattartalmazó gyógyszerkészítményekre vonatkozik. A zaleplon új,kristályos polimorf módosulatai azak a zaleplon I, II és II formák,szorongásellenes, epilepsziaellenes hatásúak, alkalmasak nyugtató-hipnotikus hatás kifejlesztésére, valamint vázizomlazításra. Ó
HU0303055A 2000-08-03 2001-08-02 Polymorphs of zaleplon and methods for the preparation thereof and pharmaceutical compositions containing them HUP0303055A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22278500P 2000-08-03 2000-08-03
PCT/US2001/024510 WO2002012244A2 (en) 2000-08-03 2001-08-02 Polymorphs of zaleplon and methods for the preparation thereof

Publications (2)

Publication Number Publication Date
HUP0303055A2 true HUP0303055A2 (hu) 2004-01-28
HUP0303055A3 HUP0303055A3 (en) 2004-11-29

Family

ID=22833666

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303055A HUP0303055A3 (en) 2000-08-03 2001-08-02 Polymorphs of zaleplon and methods for the preparation thereof and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (2) US20020072527A1 (hu)
EP (1) EP1305315A2 (hu)
JP (1) JP2004505979A (hu)
KR (2) KR20070086867A (hu)
CN (2) CN1847244A (hu)
AR (1) AR036324A1 (hu)
AU (2) AU2001283119B2 (hu)
BR (1) BR0113244A (hu)
CA (1) CA2417875C (hu)
HU (1) HUP0303055A3 (hu)
IL (1) IL154088A0 (hu)
MX (1) MXPA03001048A (hu)
NO (1) NO20030523L (hu)
NZ (1) NZ527455A (hu)
PL (1) PL365678A1 (hu)
SG (1) SG125971A1 (hu)
WO (1) WO2002012244A2 (hu)
ZA (1) ZA200300779B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200402588T3 (tr) * 2001-06-12 2004-11-22 Biogal Gyogyszergyar Rt N-[3-(3-siyanopirazolo[1,5-A]pirimidin-7-il)fenil]-N- etilasetamidin(zaleplon) üretim işlemi
US20050032818A1 (en) * 2001-06-12 2005-02-10 Entire Interest N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethylacetamide and crystalline forms of zaleplon
JP2005523874A (ja) * 2001-08-01 2005-08-11 テバ ジョジセルジャール レースベニュタールシャシャーグ Ｎ−〔３−（３−シアノピラゾロ〔１，５−ａ〕ピリミジン−７−イル）フェニル〕−Ｎ−エチルアセタミド（ザレプロン）の精製方法、及び当該方法により得られうるザレプロンの結晶型
ZA200406577B (en) * 2002-02-15 2006-06-28 Teva Gyogyzeryan Reszvenytarsa Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom
AU2002343201A1 (en) * 2002-10-16 2004-05-04 Sanmar Speciality Chemicals Limited Synthesis of zaleplon
DE112004001615T5 (de) * 2003-09-04 2006-06-14 Cipla Ltd. Zaleplon-Synthese
US20070098788A1 (en) * 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
EP1956021A1 (en) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
US20100196286A1 (en) * 2008-12-01 2010-08-05 Armer Thomas A Inhalation delivery methods and devices
WO2010074753A1 (en) * 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN102816163A (zh) * 2012-08-20 2012-12-12 四川禾邦阳光制药股份有限公司 扎来普隆的新晶型及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
KR0167261B1 (ko) * 1995-10-19 1999-04-15 문정환 전원공급 제어회로
US5714607A (en) * 1995-12-01 1998-02-03 American Cyanamid Company Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide
AR029780A1 (es) * 2000-12-13 2003-07-16 Gador Sa Procedimiento mejorado para la obtencion de n-[3(3-ciano-pirazolo[1,5-a]pirimidin-7-il)fenil]-n-etil-acetamida
JP2005523874A (ja) * 2001-08-01 2005-08-11 テバ ジョジセルジャール レースベニュタールシャシャーグ Ｎ−〔３−（３−シアノピラゾロ〔１，５−ａ〕ピリミジン−７−イル）フェニル〕−Ｎ−エチルアセタミド（ザレプロン）の精製方法、及び当該方法により得られうるザレプロンの結晶型

Also Published As

Publication number Publication date
JP2004505979A (ja) 2004-02-26
KR20070086867A (ko) 2007-08-27
CA2417875A1 (en) 2002-02-14
CN1847244A (zh) 2006-10-18
KR20030036659A (ko) 2003-05-09
US20020072527A1 (en) 2002-06-13
US20050176735A1 (en) 2005-08-11
AR036324A1 (es) 2004-09-01
AU8311901A (en) 2002-02-18
IL154088A0 (en) 2003-07-31
HUP0303055A3 (en) 2004-11-29
MXPA03001048A (es) 2004-02-26
BR0113244A (pt) 2003-07-08
WO2002012244A3 (en) 2002-06-13
CN1610682A (zh) 2005-04-27
NO20030523D0 (no) 2003-02-03
SG125971A1 (en) 2006-10-30
AU2001283119B2 (en) 2007-11-15
NO20030523L (no) 2003-03-11
NZ527455A (en) 2005-07-29
PL365678A1 (en) 2005-01-10
CA2417875C (en) 2008-12-09
EP1305315A2 (en) 2003-05-02
ZA200300779B (en) 2003-08-22
WO2002012244A2 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
HUP0302519A2 (hu) Az atorvasztatin kristályos formái, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0303055A2 (hu) Zaleplon polimorf módosulatai és eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0303808A2 (hu) Kondenzált biciklusos vagy triciklusos aminosavak, aljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
IL174902A (en) Non-neutralized and multi-specific 3cd binders, nucleic acid sequence encoding them, process for their preparation, preparation, kit, vector, surrogate cell and their use
HUP0004419A2 (hu) Aril-oxi-alkil-dialkil-amin-származékok és előállításuk
BR0113234A (pt) Polimorfos de um análogo de epotilona
ME00376B (me) DIHIDROPTERIDINONI, POSTUPAK ZA NJlHOVO PRIPREMANJE I NJlHOVA PRIMJENA KAO LIJEK
ATE311386T1 (de) Verfahren zur herstellung von 1,5,6,7- tetrahydropyrrolo(3,2-c)derivaten zur behandlung der fettleibigkeit
HUP0401538A2 (hu) Új, helyettesített aminometilcsoportot tartalmazó N-(arilszulfonil)-béta-aminosav-származékok, előállításukra alkalmas eljárás és a vegyületeket tartalmazó gyógyászati készítmények
NO20063193L (no) Fusjonerte pyrrolokarbazoler og fremgangsmater for fremstilling derav
ATE354358T1 (de) Neue sertralinhydrochlorid polymorphe, verfahren zur herstellung und zur verwendung und diese enthaltende zusammensetzungen
DE69813792D1 (de) Zwischenprodukte und verfahren zu ihrer herstellung
DE60229267D1 (de) Oxopyrrolidin verbindungen, verfahren zur herstellung dieser verbindungen und deren verwendung zur herstellung von levetiracetam und analogen
HUP0302874A2 (hu) Eljárás risperidon előállítására
HUP0204318A2 (en) Torsemide polymorphic forms, process for their preparation, pharmaceutical compositions containing them and their use
HUP0402253A2 (hu) Eljárás N-[3-(3-ciano-pirazolo[1,5-a]pirimidin-7-il)-fenil]-N-etil-acetamid (zaleplon) tisztítására és új kristályformáinak előállítására, valamint az új kristályformákat tartalmazó gyógyszerkészítmények
KR20070107083A (ko) 냉각 특성을 갖는 멘탄 카복스아마이드 유도체
DE69627166D1 (de) Verfahren zur herstellung von 2-chlor-5-chlomethyl-thiazol-derivaten
ATE401332T1 (de) Neue polymorphe von olanzapin-hydrochlorid
IL159281A0 (en) Process for the production of n-[3-(3-cyanopyrazolo{1,5-a} pyrimidin-7-yl) phenyl]-n-ethylacetamide (zaleplon)
DE60235365D1 (de) Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
DE60324607D1 (de) Pyrrolo(2,1-c)(1,4)benzodiazepin-dimere als antitumormittel und verfahren dafür
NO20020645D0 (no) Syntese av substituerte pyrazolopyrimidiner
ATE300534T1 (de) Verfahren und zwischenverbindungen zur herstellung von imidazopyridinen
SE9800865D0 (sv) New Process

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: MEDA AB, SE

Free format text: FORMER OWNER(S): WYETH, US

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished